(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ZMAT3 mRNA] CTD PMID:31150632 (-)-demecolcine increases expression ISO RGD:1602466 6480464 Demecolcine results in increased expression of ZMAT3 mRNA CTD PMID:23649840 1,1-dichloroethene increases expression ISO RGD:1552389 6480464 vinylidene chloride results in increased expression of ZMAT3 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:1552389 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZMAT3 mRNA CTD PMID:22206623 1-nitropropane decreases expression EXP 6480464 1-nitropropane results in decreased expression of ZMAT3 mRNA CTD PMID:17070881 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ZMAT3 mRNA CTD PMID:15212814 , PMID:29097150 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552389 6480464 Tetrachlorodibenzodioxin affects the expression of ZMAT3 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ZMAT3 mRNA CTD PMID:33387578 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-diaminotoluene increases expression EXP 6480464 2, 4-diaminotoluene results in increased expression of ZMAT3 mRNA CTD PMID:17070881 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ZMAT3 mRNA CTD PMID:21346803 2,6-diaminotoluene increases expression EXP 6480464 2, 6-diaminotoluene results in increased expression of ZMAT3 mRNA CTD PMID:17070881 2-acetamidofluorene multiple interactions ISO RGD:1552389 6480464 TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of ZMAT3 mRNA] CTD PMID:17317680 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of ZMAT3 mRNA CTD PMID:17070881 more ... 2-acetamidofluorene increases expression ISO RGD:1552389 6480464 2-Acetylaminofluorene results in increased expression of ZMAT3 mRNA CTD PMID:17317680 , PMID:21607683 2-nitro-p-phenylenediamine decreases expression EXP 6480464 2-nitro-4-phenylenediamine results in decreased expression of ZMAT3 mRNA CTD PMID:17070881 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of ZMAT3 mRNA CTD PMID:14600272 , PMID:15890375 2-nitropropane increases expression EXP 6480464 2-nitropropane results in increased expression of ZMAT3 mRNA CTD PMID:17070881 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1602466 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZMAT3 mRNA CTD PMID:28628672 3-methylcholanthrene multiple interactions ISO RGD:1602466 6480464 Methylcholanthrene promotes the reaction [AHR protein binds to ZMAT3 promoter] CTD PMID:20348232 4,4'-sulfonyldiphenol affects methylation ISO RGD:1552389 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of ZMAT3 gene CTD PMID:31683443 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of ZMAT3 mRNA CTD PMID:14600272 , PMID:15890375 4-acetylaminofluorene decreases expression EXP 6480464 4-acetylaminofluorene results in decreased expression of ZMAT3 mRNA CTD PMID:17070881 4-hydroxynon-2-enal increases expression ISO RGD:1552389 6480464 4-hydroxy-2-nonenal results in increased expression of ZMAT3 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1552389 6480464 Fenretinide results in increased expression of ZMAT3 mRNA CTD PMID:28973697 4-nitro-1,2-phenylenediamine increases expression EXP 6480464 1, 2-diamino-4-nitrobenzene results in increased expression of ZMAT3 mRNA CTD PMID:17070881 5-aza-2'-deoxycytidine affects expression ISO RGD:1602466 6480464 Decitabine affects the expression of ZMAT3 mRNA CTD PMID:23300844 5-fluorouracil multiple interactions ISO RGD:1602466 6480464 TP53 protein promotes the reaction [Fluorouracil results in increased expression of ZMAT3 mRNA] CTD PMID:17982676 5-fluorouracil increases expression ISO RGD:1602466 6480464 Fluorouracil results in increased expression of ZMAT3 mRNA CTD PMID:17982676 acetamide increases expression EXP 6480464 acetamide results in increased expression of ZMAT3 mRNA CTD PMID:31881176 adefovir pivoxil increases expression ISO RGD:1602466 6480464 adefovir dipivoxil results in increased expression of ZMAT3 mRNA CTD PMID:25596134 aflatoxin B1 affects expression ISO RGD:1602466 6480464 Aflatoxin B1 affects the expression of ZMAT3 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of ZMAT3 mRNA CTD PMID:15890375 more ... aflatoxin B1 increases expression ISO RGD:1602466 6480464 Aflatoxin B1 results in increased expression of ZMAT3 mRNA CTD PMID:21641981 aflatoxin B1 increases expression ISO RGD:1552389 6480464 Aflatoxin B1 results in increased expression of ZMAT3 mRNA CTD PMID:19770486 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ZMAT3 mRNA CTD PMID:16483693 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of ZMAT3 mRNA CTD PMID:30779732 atrazine increases expression ISO RGD:1602466 6480464 Atrazine results in increased expression of ZMAT3 mRNA CTD PMID:22378314 belinostat increases expression ISO RGD:1602466 6480464 belinostat results in increased expression of ZMAT3 mRNA CTD PMID:27188386 benzene multiple interactions ISO RGD:1552389 6480464 TRP53 protein affects the reaction [Benzene results in increased expression of ZMAT3 mRNA] CTD PMID:12928149 benzene increases expression ISO RGD:1552389 6480464 Benzene results in increased expression of ZMAT3 mRNA CTD PMID:12928149 more ... benzo[a]pyrene increases expression ISO RGD:1602466 6480464 Benzo(a)pyrene results in increased expression of ZMAT3 mRNA CTD PMID:21632981 more ... benzo[a]pyrene increases methylation ISO RGD:1602466 6480464 Benzo(a)pyrene results in increased methylation of ZMAT3 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1552389 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZMAT3 mRNA, [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of ZMAT3 mRNA] CTD PMID:14625279 , PMID:27858113 benzo[a]pyrene increases expression ISO RGD:1552389 6480464 Benzo(a)pyrene results in increased expression of ZMAT3 mRNA CTD PMID:14625279 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1602466 6480464 7 more ... CTD PMID:20018196 benzo[b]fluoranthene increases expression ISO RGD:1552389 6480464 benzo(b)fluoranthene results in increased expression of ZMAT3 mRNA CTD PMID:26377693 benzo[b]fluoranthene multiple interactions ISO RGD:1552389 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZMAT3 mRNA CTD PMID:27858113 benzo[e]pyrene decreases methylation ISO RGD:1602466 6480464 benzo(e)pyrene results in decreased methylation of ZMAT3 intron CTD PMID:30157460 bicalutamide increases expression ISO RGD:1602466 6480464 bicalutamide results in increased expression of ZMAT3 mRNA CTD PMID:15638997 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ZMAT3 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1602466 6480464 bisphenol A results in increased expression of ZMAT3 mRNA CTD PMID:33670352 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ZMAT3 mRNA CTD PMID:29097150 , PMID:34947998 bisphenol F multiple interactions ISO RGD:1602466 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZMAT3 mRNA CTD PMID:28628672 butan-1-ol multiple interactions ISO RGD:1602466 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ZMAT3 mRNA CTD PMID:29432896 cadmium dichloride increases expression ISO RGD:1602466 6480464 Cadmium Chloride results in increased expression of ZMAT3 mRNA CTD PMID:25596134 carbamazepine affects expression ISO RGD:1602466 6480464 Carbamazepine affects the expression of ZMAT3 mRNA CTD PMID:25979313 chloroacetaldehyde increases expression ISO RGD:1602466 6480464 chloroacetaldehyde results in increased expression of ZMAT3 mRNA CTD PMID:25596134 chrysene multiple interactions ISO RGD:1552389 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZMAT3 mRNA CTD PMID:27858113 cidofovir anhydrous increases expression ISO RGD:1602466 6480464 Cidofovir results in increased expression of ZMAT3 mRNA CTD PMID:25596134 cisplatin multiple interactions ISO RGD:1602466 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of ZMAT3 mRNA CTD PMID:21858171 cisplatin increases expression ISO RGD:1602466 6480464 Cisplatin results in increased expression of ZMAT3 mRNA CTD PMID:21532991 , PMID:25596134 cisplatin decreases expression ISO RGD:1602466 6480464 Cisplatin results in decreased expression of ZMAT3 mRNA CTD PMID:27594783 cisplatin affects expression ISO RGD:1602466 6480464 Cisplatin affects the expression of ZMAT3 mRNA CTD PMID:23300844 cisplatin increases expression ISO RGD:1552389 6480464 Cisplatin results in increased expression of ZMAT3 mRNA CTD PMID:21151649 cobalt dichloride increases expression ISO RGD:1602466 6480464 cobaltous chloride results in increased expression of ZMAT3 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:1602466 6480464 [Chelating Agents binds to Copper] which results in increased expression of ZMAT3 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:1602466 6480464 [Chelating Agents binds to Copper] which results in increased expression of ZMAT3 mRNA CTD PMID:30911355 crocidolite asbestos increases expression ISO RGD:1552389 6480464 Asbestos, Crocidolite results in increased expression of ZMAT3 mRNA CTD PMID:19446018 daunorubicin increases expression ISO RGD:1602466 6480464 Daunorubicin results in increased expression of ZMAT3 mRNA CTD PMID:26537877 , PMID:28940058 dexamethasone multiple interactions ISO RGD:1602466 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZMAT3 mRNA CTD PMID:28628672 diazinon affects expression EXP 6480464 Diazinon affects the expression of ZMAT3 mRNA CTD PMID:22546817 dibenz[a,h]anthracene increases expression ISO RGD:1552389 6480464 1 more ... CTD PMID:26377693 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of ZMAT3 mRNA CTD PMID:22546817 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of ZMAT3 mRNA CTD PMID:15890375 dioxygen decreases expression ISO RGD:1602466 6480464 Oxygen deficiency results in decreased expression of ZMAT3 mRNA CTD PMID:25596134 dioxygen multiple interactions ISO RGD:1552389 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of ZMAT3 mRNA, [sulforaphane affects the susceptibility to Oxygen] which affects the expression of ZMAT3 mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1602466 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1602466 6480464 Doxorubicin results in increased expression of ZMAT3 mRNA CTD PMID:16439685 more ... doxorubicin affects expression ISO RGD:1602466 6480464 Doxorubicin affects the expression of ZMAT3 mRNA CTD PMID:29803840 entinostat increases expression ISO RGD:1602466 6480464 entinostat results in increased expression of ZMAT3 mRNA CTD PMID:27188386 ethanol affects splicing ISO RGD:1552389 6480464 Ethanol affects the splicing of ZMAT3 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1602466 6480464 Ethyl Methanesulfonate results in increased expression of ZMAT3 mRNA CTD PMID:23649840 etoposide increases expression ISO RGD:1602466 6480464 Etoposide results in increased expression of ZMAT3 mRNA CTD PMID:29397400 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of ZMAT3 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:1552389 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ZMAT3 mRNA CTD PMID:22206623 formaldehyde increases expression ISO RGD:1602466 6480464 Formaldehyde results in increased expression of ZMAT3 mRNA CTD PMID:23649840 furan increases expression ISO RGD:1552389 6480464 furan results in increased expression of ZMAT3 mRNA CTD PMID:24183702 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of ZMAT3 mRNA CTD PMID:33387578 ibuprofen increases expression ISO RGD:1602466 6480464 Ibuprofen results in increased expression of ZMAT3 mRNA CTD PMID:25596134 ifosfamide increases expression ISO RGD:1602466 6480464 Ifosfamide results in increased expression of ZMAT3 mRNA CTD PMID:25596134 indometacin multiple interactions ISO RGD:1602466 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ZMAT3 mRNA CTD PMID:28628672 leflunomide increases expression ISO RGD:1552389 6480464 leflunomide results in increased expression of ZMAT3 mRNA CTD PMID:19751817 mercury dibromide increases expression ISO RGD:1602466 6480464 mercuric bromide results in increased expression of ZMAT3 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1602466 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZMAT3 mRNA CTD PMID:27188386 methamphetamine increases expression ISO RGD:1552389 6480464 Methamphetamine results in increased expression of ZMAT3 protein CTD PMID:17234339 methamphetamine affects response to substance EXP 6480464 ZMAT3 protein affects the susceptibility to Methamphetamine CTD PMID:17234339 methamphetamine affects response to substance ISO RGD:1552389 6480464 ZMAT3 protein affects the susceptibility to Methamphetamine CTD PMID:17234339 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of ZMAT3 mRNA CTD PMID:15890375 methapyrilene decreases methylation ISO RGD:1602466 6480464 Methapyrilene results in decreased methylation of ZMAT3 intron CTD PMID:30157460 methyl methanesulfonate increases expression ISO RGD:1602466 6480464 Methyl Methanesulfonate results in increased expression of ZMAT3 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1602466 6480464 methylmercuric chloride results in increased expression of ZMAT3 mRNA CTD PMID:23179753 more ... methylmercury chloride multiple interactions ISO RGD:1602466 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZMAT3 mRNA CTD PMID:27188386 mitoxantrone increases expression ISO RGD:1602466 6480464 Mitoxantrone results in increased expression of ZMAT3 mRNA CTD PMID:26537877 , PMID:28940058 N-nitrosodiethylamine increases expression ISO RGD:1552389 6480464 Diethylnitrosamine results in increased expression of ZMAT3 mRNA CTD PMID:21607683 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of ZMAT3 mRNA CTD PMID:14600272 , PMID:15890375 Nutlin-3 increases expression ISO RGD:1602466 6480464 nutlin 3 results in increased expression of ZMAT3 mRNA, nutlin 3 results in increased expression of ZMAT3 protein CTD PMID:16439685 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of ZMAT3 mRNA CTD PMID:23358140 ochratoxin A decreases expression ISO RGD:1602466 6480464 ochratoxin A results in decreased expression of ZMAT3 mRNA CTD PMID:30559759 paracetamol affects expression ISO RGD:1552389 6480464 Acetaminophen affects the expression of ZMAT3 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1602466 6480464 Acetaminophen results in increased expression of ZMAT3 mRNA CTD PMID:22230336 , PMID:26690555 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of ZMAT3 mRNA CTD PMID:19162173 phenylmercury acetate increases expression ISO RGD:1602466 6480464 Phenylmercuric Acetate results in increased expression of ZMAT3 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1602466 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZMAT3 mRNA CTD PMID:27188386 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of ZMAT3 mRNA CTD PMID:15890375 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ZMAT3 mRNA CTD PMID:15890375 piroxicam multiple interactions ISO RGD:1602466 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of ZMAT3 mRNA CTD PMID:21858171 potassium bromate increases expression ISO RGD:1602466 6480464 potassium bromate results in increased expression of ZMAT3 mRNA CTD PMID:30559759 potassium chromate multiple interactions ISO RGD:1552389 6480464 [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of ZMAT3 mRNA] CTD PMID:14625279 potassium dichromate multiple interactions ISO RGD:1552389 6480464 [Potassium Dichromate co-treated with potassium chromate(VI)] inhibits the reaction [Benzo(a)pyrene results in increased expression of ZMAT3 mRNA] CTD PMID:14625279 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of ZMAT3 mRNA CTD PMID:19162173 quercetin increases expression ISO RGD:1602466 6480464 Quercetin results in increased expression of ZMAT3 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO RGD:1602466 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of ZMAT3 mRNA CTD PMID:23557933 Salinomycin decreases expression ISO RGD:1602466 6480464 salinomycin results in decreased expression of ZMAT3 mRNA CTD PMID:19682730 SB 431542 multiple interactions ISO RGD:1602466 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1552389 6480464 Silicon Dioxide results in decreased expression of ZMAT3 mRNA CTD PMID:19073995 sulforaphane decreases expression ISO RGD:1552389 6480464 sulforaphane results in decreased expression of ZMAT3 mRNA CTD PMID:30529165 sulforaphane multiple interactions ISO RGD:1552389 6480464 [sulforaphane affects the susceptibility to Oxygen] which affects the expression of ZMAT3 mRNA CTD PMID:30529165 sunitinib increases expression ISO RGD:1602466 6480464 Sunitinib results in increased expression of ZMAT3 mRNA CTD PMID:31533062 temozolomide decreases expression ISO RGD:1602466 6480464 Temozolomide results in decreased expression of ZMAT3 mRNA CTD PMID:31758290 testosterone decreases expression ISO RGD:1602466 6480464 Testosterone results in decreased expression of ZMAT3 mRNA CTD PMID:33359661 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ZMAT3 mRNA CTD PMID:16644059 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ZMAT3 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ZMAT3 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1552389 6480464 Carbon Tetrachloride results in increased expression of ZMAT3 mRNA CTD PMID:27339419 , PMID:31919559 tetraphene multiple interactions ISO RGD:1552389 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZMAT3 mRNA CTD PMID:27858113 thapsigargin increases expression ISO RGD:1602466 6480464 Thapsigargin results in increased expression of ZMAT3 mRNA CTD PMID:22378314 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ZMAT3 mRNA CTD PMID:23411599 , PMID:34492290 tipifarnib increases expression EXP 6480464 tipifarnib results in increased expression of ZMAT3 mRNA CTD PMID:16403772 titanium dioxide increases expression ISO RGD:1552389 6480464 titanium dioxide results in increased expression of ZMAT3 mRNA CTD PMID:23409001 titanium dioxide decreases expression ISO RGD:1552389 6480464 titanium dioxide results in decreased expression of ZMAT3 mRNA CTD PMID:29264374 trichostatin A increases expression ISO RGD:1602466 6480464 trichostatin A results in increased expression of ZMAT3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1602466 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZMAT3 mRNA CTD PMID:27188386 Triptolide increases expression ISO RGD:1552389 6480464 triptolide results in increased expression of ZMAT3 mRNA CTD PMID:32835833 trovafloxacin increases expression ISO RGD:1552389 6480464 trovafloxacin results in increased expression of ZMAT3 mRNA CTD PMID:35537566 tunicamycin decreases expression ISO RGD:1552389 6480464 Tunicamycin results in decreased expression of ZMAT3 mRNA CTD PMID:17127020 tunicamycin increases expression ISO RGD:1602466 6480464 Tunicamycin results in increased expression of ZMAT3 mRNA CTD PMID:22378314 urethane decreases expression ISO RGD:1602466 6480464 Urethane results in decreased expression of ZMAT3 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:1602466 6480464 Valproic Acid results in decreased expression of ZMAT3 mRNA CTD PMID:29154799 valproic acid increases expression ISO RGD:1602466 6480464 Valproic Acid results in increased expression of ZMAT3 mRNA CTD PMID:19101580 more ... valproic acid decreases methylation ISO RGD:1602466 6480464 Valproic Acid results in decreased methylation of ZMAT3 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1602466 6480464 Valproic Acid affects the expression of ZMAT3 mRNA CTD PMID:25979313 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of ZMAT3 mRNA CTD PMID:23034163 vincristine increases expression ISO RGD:1602466 6480464 Vincristine results in increased expression of ZMAT3 mRNA CTD PMID:23649840 vorinostat increases expression ISO RGD:1602466 6480464 vorinostat results in increased expression of ZMAT3 mRNA CTD PMID:27188386
